Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
| Autor: | Li, Kezhen *, Chen, Jing *, Hu, Yingjie *, Wang, Yan-Zhou *, Shen, Yuanming *, Chen, Gang *, Peng, Wenju, Fang, Zixuan, Xia, Bairong, Chen, Xiaojun, Song, Kun, Wang, Yingmei, Zou, Dongling, Wang, Yan-Chun, Han, Yingyan, Feng, Xue, Yuan, Jing, Guo, Shuaiqingying, Meng, Xiaolin, Feng, Chenzhao, Chen, Yin, Yang, Jie, Fan, Junpeng, Wang, Jianliu, Ai, Jihui †, Ma, Ding †, Sun, Chaoyang †, * |
|---|---|
| Zdroj: | In The Lancet Oncology January 2024 25(1):76-85 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|